INCR revenueFY2025ILS 270.20M
- FY YoY
- +13.1%
- 5Y CAGR
- +33.0%
INCR revenue was ILS 270.20M for fiscal 2025 (ended Dec 31, 2025), up 13.1% from fiscal 2024. Compound annual growth was +33.0% over 5 years. It rose in 4 of the last 6 fiscal years.
For fiscal 2025 (ended Dec 31, 2025), Intercure Ltd. reported ILS 270.20M of revenue and -ILS 35.71M of net income. Figures are in ILS, the currency of its SEC filings.
INCR revenue was ILS 270.20M for fiscal 2025 (ended Dec 31, 2025), up 13.1% from fiscal 2024. Compound annual growth was +33.0% over 5 years. It rose in 4 of the last 6 fiscal years.
INCR net income was -ILS 35.71M for fiscal 2025 (ended Dec 31, 2025), compared with -ILS 67.80M in fiscal 2024.
INCR diluted EPS was -ILS 0.66 for fiscal 2025 (ended Dec 31, 2025), compared with -ILS 1.48 in fiscal 2024.
INCR free cash flow was ILS 13.29M for fiscal 2025 (ended Dec 31, 2025), compared with -ILS 71.30M in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | ILS 270.20M | ILS 238.84M | ILS 355.55M | ILS 388.68M | ILS 219.68M | ILS 65.03M | ILS 8.93M |
| Cost of revenue | ILS 229.52M | ILS 203.25M | ILS 247.21M | ILS 229.73M | ILS 123.69M | ILS 34.65M | ILS 7.46M |
| Gross profit | ILS 33.18M | ILS 30.23M | ILS 105.09M | ILS 155.08M | ILS 91.13M | ILS 31.98M | ILS 1.48M |
| Research and development | ILS 390.0K | ILS 414.0K | ILS 388.0K | ILS 632.0K | ILS 1.24M | ILS 1.58M | ILS 1.71M |
| Selling, general and admin | ILS 40.89M | ILS 53.67M | ILS 42.61M | ILS 36.08M | ILS 27.21M | ILS 8.59M | ILS 12.07M |
| Operating income | -ILS 27.24M | -ILS 67.21M | -ILS 41.57M | ILS 50.63M | ILS 28.18M | -ILS 38.40M | -ILS 3.42M |
| Pre-tax income | -ILS 44.10M | -ILS 87.32M | -ILS 61.28M | ILS 43.84M | ILS 18.73M | -ILS 38.31M | -ILS 6.57M |
| Income tax | -ILS 7.32M | -ILS 14.53M | ILS 2.25M | ILS 93.0K | ILS 11.44M | -ILS 2.27M | -ILS 673.0K |
| Net income | -ILS 35.71M | -ILS 67.80M | -ILS 61.96M | ILS 44.82M | ILS 4.69M | -ILS 37.23M | -ILS 5.89M |
| EPS, basic | -ILS 0.66 | -ILS 1.48 | -ILS 1.36 | ILS 0.99 | ILS 0.12 | -ILS 1.42 | -ILS 0.25 |
| EPS, diluted | -ILS 0.66 | -ILS 1.48 | -ILS 1.36 | ILS 0.99 | ILS 0.11 | -ILS 1.42 | -ILS 0.25 |
| Diluted shares | 53.7M | 45.9M | 45.6M | 45.4M | 38.5M | 25.4M | 23.3M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | ILS 46.47M | ILS 78.32M | ILS 101.14M | ILS 232.59M | ILS 196.22M | ILS 37.89M | ILS 27.34M |
| Short-term investments | ILS 122.0K | ILS 2.15M | ILS 1.92M | ILS 205.0K | ILS 330.0K | ILS 376.0K | - |
| Inventory | ILS 108.01M | ILS 120.31M | ILS 105.47M | ILS 140.13M | ILS 62.31M | ILS 19.05M | - |
| Current assets | - | ILS 391.80M | ILS 418.80M | ILS 527.49M | ILS 336.16M | ILS 76.65M | - |
| Goodwill | ILS 219.19M | ILS 224.59M | ILS 221.08M | ILS 284.18M | ILS 268.29M | ILS 190.10M | - |
| Total assets | ILS 690.55M | ILS 762.57M | ILS 786.61M | ILS 958.01M | ILS 696.54M | ILS 326.27M | ILS 282.23M |
| Current liabilities | ILS 214.37M | ILS 226.75M | ILS 225.87M | ILS 312.72M | ILS 193.59M | ILS 29.88M | - |
| Long-term debt | ILS 59.46M | ILS 113.98M | ILS 82.20M | ILS 99.68M | ILS 11.88M | ILS 388.0K | - |
| Total debt | ILS 59.46M | ILS 113.98M | ILS 82.20M | ILS 99.68M | ILS 11.88M | ILS 388.0K | - |
| Total liabilities | ILS 294.19M | ILS 364.90M | ILS 329.55M | ILS 436.53M | ILS 227.13M | ILS 34.16M | -ILS 26.03M |
| Shareholders' equity | ILS 396.52M | ILS 396.97M | ILS 457.06M | ILS 521.48M | ILS 469.41M | ILS 292.11M | ILS 256.20M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | ILS 16.84M | -ILS 66.93M | -ILS 53.63M | ILS 51.27M | ILS 30.14M | ILS 7.90M | -ILS 11.57M |
| Capital expenditures | ILS 3.55M | ILS 4.38M | ILS 2.62M | ILS 19.74M | ILS 14.03M | ILS 20.84M | ILS 28.14M |
| Free cash flow | ILS 13.29M | -ILS 71.30M | -ILS 56.25M | ILS 31.52M | ILS 16.11M | -ILS 12.95M | -ILS 39.71M |
| Investing cash flow | -ILS 1.99M | ILS 17.69M | ILS 4.77M | -ILS 142.50M | -ILS 65.21M | -ILS 22.76M | -ILS 26.09M |
| Financing cash flow | -ILS 46.66M | ILS 26.45M | -ILS 82.89M | ILS 120.45M | ILS 197.94M | ILS 25.20M | ILS 63.23M |
| Stock-based compensation | ILS 2.43M | ILS 2.28M | ILS 2.59M | ILS 8.91M | ILS 6.45M | ILS 10.01M | ILS 68.04M |
| Depreciation and amortization | ILS 17.15M | ILS 15.37M | ILS 13.17M | ILS 11.70M | ILS 7.39M | ILS 3.25M | ILS 828.0K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 13.1% | -32.8% | -8.5% | 76.9% | 237.8% | 628.6% | - |
| Net income growth, YoY | - | - | - | 855.6% | - | - | - |
| EPS growth, YoY | - | - | - | 800.0% | - | - | - |
| Gross margin | 12.3% | 12.7% | 29.6% | 39.9% | 41.5% | 49.2% | 16.6% |
| Operating margin | -10.1% | -28.1% | -11.7% | 13.0% | 12.8% | -59.0% | -38.3% |
| Net margin | -13.2% | -28.4% | -17.4% | 11.5% | 2.1% | -57.2% | -66.0% |
| Free cash flow margin | 4.9% | -29.9% | -15.8% | 8.1% | 7.3% | -19.9% | -444.9% |
| Return on equity | -9.0% | -17.1% | -13.6% | 8.6% | 1.0% | -12.7% | -2.3% |
| Return on assets | -5.2% | -8.9% | -7.9% | 4.7% | 0.7% | -11.4% | -2.1% |
| Current ratio | - | 1.73 | 1.85 | 1.69 | 1.74 | 2.57 | - |
| Debt to equity | 0.15 | 0.29 | 0.18 | 0.19 | 0.03 | 0.00 | - |
Source: XBRL data Intercure Ltd. files with the SEC, latest filing dated Apr 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| INCR | ILS 270.20M | +13.1% | -ILS 35.71M | -13.2% | $56.9M |
| TLRY | $963.10M | +15.9% | -$164.22M | -17.1% | $359.1M |
| CGC | C$407.88M | +14.4% | -C$268.34M | -65.8% | $238.7M |
| ACB | C$320.59M | +11.0% | -C$135.96M | -42.4% | $324.8M |
| CRON | $271.85M | +54.3% | $63.36M | 23.3% | $1.24B |
| SNDL | C$1.00B | +2.8% | -C$15.77M | -1.6% | $333.3M |
| OGI | C$259.18M | +62.2% | -C$24.76M | -9.6% | $117.6M |